PETER J HYNES

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease SEA GIRT, NJ NPI 1497953210

General Payments — all program years on this page

$8,097.29

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 592
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $416.30 across 37 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $416.3037

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $2,029.13147
2019 $1,418.65101
2020 $903.4666
2021 $1,244.8997
2022 $878.2271
2023 $1,206.6473
2024 $416.3037

Records — PY2024 (37)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078901377 Actelion Pharmaceuticals US, Inc. $13.39 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078901379 Actelion Pharmaceuticals US, Inc. $16.98 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086891969 Novartis Pharmaceuticals Corporation $5.36 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086891971 Novartis Pharmaceuticals Corporation $4.96 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086891973 Novartis Pharmaceuticals Corporation $12.72 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086891975 Novartis Pharmaceuticals Corporation $7.08 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086891981 Novartis Pharmaceuticals Corporation $5.30 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086891983 Novartis Pharmaceuticals Corporation $9.84 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086891989 Novartis Pharmaceuticals Corporation $5.12 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086891995 Novartis Pharmaceuticals Corporation $21.73 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086891997 Novartis Pharmaceuticals Corporation $6.23 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086891999 Novartis Pharmaceuticals Corporation $15.17 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892003 Novartis Pharmaceuticals Corporation $5.17 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892011 Novartis Pharmaceuticals Corporation $23.93 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892013 Novartis Pharmaceuticals Corporation $5.70 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892019 Novartis Pharmaceuticals Corporation $6.77 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892021 Novartis Pharmaceuticals Corporation $6.37 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892027 Novartis Pharmaceuticals Corporation $17.66 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892029 Novartis Pharmaceuticals Corporation $7.32 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892031 Novartis Pharmaceuticals Corporation $5.51 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892033 Novartis Pharmaceuticals Corporation $9.53 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892035 Novartis Pharmaceuticals Corporation $15.80 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892037 Novartis Pharmaceuticals Corporation $8.35 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892047 Novartis Pharmaceuticals Corporation $2.69 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892049 Novartis Pharmaceuticals Corporation $6.15 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892051 Novartis Pharmaceuticals Corporation $6.15 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086892053 Novartis Pharmaceuticals Corporation $9.04 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097047171 Novo Nordisk Inc $15.32 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104299502 AstraZeneca Pharmaceuticals LP $13.60 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104670119 AstraZeneca Pharmaceuticals LP $13.64 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118035231 Boehringer Ingelheim Pharmaceuticals, Inc. $13.98 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118035233 Boehringer Ingelheim Pharmaceuticals, Inc. $15.12 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118035235 Boehringer Ingelheim Pharmaceuticals, Inc. $15.51 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118035237 Boehringer Ingelheim Pharmaceuticals, Inc. $15.99 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132045270 PFIZER INC. $18.27 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139785713 SANOFI-AVENTIS U.S. LLC $17.85 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154890483 Kiniksa Pharmaceuticals International, plc $17.00 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.